IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases the amount of ATXN3. 2 / 2

| 2

reach

"MG132 treatment was able to reduce full-length human ataxin-3 84Q levels (p = 0.0477) whilst cleaved ataxin-3 levels was not affected (Figure 5L,(Mi,Mii); p = 0.0942, n = 4)."

36980234

➶

reach

"Proteasome inhibitor MG132 increased the steady-state levels of ataxin-3 (both normal [26Q] and polyQ expanded [73Q] forms) to a certain extent."

30460066

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases the amount of ATXN3. 2 / 2

INDRA sources:

Databases

Reading